Second Line Sorafenib After Pazopanib in Patients With RCC
Clinical trial NCT02122003 · TERMINATED
Trial details
- NCT number
- NCT02122003
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-11-08
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.